Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07539519 · ClinicalTrials.gov registry record · NA
A Toolkit to Improve Mental Health Treatment for Autistic Individuals
A NA study, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07539519: Recruiting NA study, sponsored by Florida International University.
NCT07539519 is a NA study that is actively recruiting participants, run by Florida International University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07539519, a NA study, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on results, we will develop a prototype of a resource for therapists. This resource will be pilot tested in a community clinic.
Primary Outcome
The Acceptability of Intervention Measure includes four items rated on a five-point scale (1= "Completely Disagree"; 5 = "Completely Agree"). Items are averaged to produce an acceptability score. Higher scores indicate greater acceptability.
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL Enhanced Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07539519 shows while recruiting
NCT07539519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT07539519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07539519 about?
NCT07539519 is a clinical study titled "A Toolkit to Improve Mental Health Treatment for Autistic Individuals". This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on...
What is the current status of trial NCT07539519?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-04-09. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07539519?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Enhanced Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07539519?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07539519's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI